Human testing of first Nipah virus vaccine begins
11 months, 1 week ago

Human testing of first Nipah virus vaccine begins

India Today  

After successful preclinical trials of a vaccine candidate, called ChAdOx1 NiV, for the brain-swelling Nipah virus, it has entered the human testing phase. Conducted by the University of Oxford with 52 participants, the human trial will assess safety and immune response in individuals aged 18 to 55, a spokesperson for the University's Pandemic Sciences Institute told news agency Reuters. While Oxford Vaccine Group is leading the trial, the human testing is being funded by CEPI, a global coalition that supports the development of vaccines against emerging infectious diseases. Nipah virus infection is a zoonotic illness spread to humans through contact with infected animals such as bats and pigs.

History of this topic

Nipah test results of 13 people turn -ve, no new cases in state
5 months ago
Oxford scientists launch first human vaccine trials for deadly Nipah virus
11 months, 1 week ago
The science behind Nipah vaccine: How ChAdOx1 NipahB vaccine works
11 months, 1 week ago
ICMR considers developing vaccine against Nipah
1 year, 3 months ago
Nipah virus outbreak | India reaches out to Australia for monoclonal antibody doses
1 year, 3 months ago
What is Nipah Virus? Symptoms, diagnosis and treatment
1 year, 3 months ago
Why The World Should Be More Than A Bit Worried About India's Nipah Virus Outbreak
3 years, 3 months ago
Twelve-yr-old in Kerala succumbs to Nipah virus infection; symptoms, origin, causes of disease
3 years, 3 months ago

Discover Related